Suppr超能文献

甲状腺激素敏感性受损与糖尿病和代谢综合征有关。

Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome.

机构信息

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain

Translational Research Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain.

出版信息

Diabetes Care. 2019 Feb;42(2):303-310. doi: 10.2337/dc18-1410. Epub 2018 Dec 14.

Abstract

OBJECTIVE

Diabetes prevalence and incidence increase among individuals with hypothyroidism but also among those with hyperthyroxinemia, which seems contradictory. Both high free thyroxine (fT4) and high thyroid-stimulating hormone (TSH) are present in the resistance to thyroid hormone syndrome. A mild acquired resistance to thyroid hormone might occur in the general population and be associated with diabetes. We aimed to analyze the association of resistance to thyroid hormone indices (the Thyroid Feedback Quantile-based Index [TFQI], proposed in this work, and the previously used Thyrotroph T4 Resistance Index and TSH Index) with diabetes.

RESEARCH DESIGN AND METHODS

We calculated the aforementioned resistance to thyroid hormone indices based on a U.S. representative sample of 5,129 individuals ≥20 years of age participating in the 2007-2008 National Health and Nutrition Examination Survey (NHANES). Also, to approximate TFQI, a U.S.-referenced Parametric TFQI (PTFQI) can be calculated with the spreadsheet formula =NORM.DIST(fT4_cell_in_pmol_per_L,10.075,2.155,TRUE)+NORM.DIST(LN(TSH_cell_in_mIU_per_L),0.4654,0.7744,TRUE)-1. Outcomes of interest were glycohemoglobin ≥6.5%, diabetes medication, diabetes-related deaths (diabetes as contributing cause of death), and additionally, in a fasting subsample, diabetes and metabolic syndrome. Logistic and Poisson regressions were adjusted for sex, age, and race/ethnicity.

RESULTS

Odd ratios for the fourth versus the first quartile of TFQI were 1.73 (95% CI 1.32, 2.27) ( = 0.002) for positive glycohemoglobin and 1.66 (95% CI 1.31, 2.10) ( = 0.001) for medication. Diabetes-related death rate ratio for TFQI being above versus below the median was 4.81 (95% CI 1.01, 22.94) ( = 0.015). Further adjustment for BMI and restriction to normothyroid individuals yielded similar results. Per 1 SD in TFQI, odds increased 1.13 (95% CI 1.02, 1.25) for diabetes and 1.16 (95% CI 1.02, 1.31) for metabolic syndrome. The other resistance to thyroid hormone indices showed similar associations for diabetes-related deaths and metabolic syndrome.

CONCLUSIONS

Higher values in resistance to thyroid hormone indices are associated with obesity, metabolic syndrome, diabetes, and diabetes-related mortality. Resistance to thyroid hormone may reflect energy balance problems driving type 2 diabetes. These indices may facilitate monitoring treatments focused on energy balance.

摘要

目的

甲状腺功能减退症和甲状腺功能亢进症患者的糖尿病患病率和发病率均增加,但这似乎存在矛盾。在甲状腺激素抵抗综合征中,游离甲状腺素(fT4)和促甲状腺激素(TSH)均升高。人群中可能存在轻度获得性甲状腺激素抵抗,且与糖尿病相关。本研究旨在分析甲状腺激素抵抗指数(本研究中提出的甲状腺反馈定量指数[TFQI],以及先前使用的促甲状腺激素 T4 抵抗指数和 TSH 指数)与糖尿病之间的关系。

研究设计和方法

我们根据美国≥20 岁的 5129 名参与 2007-2008 年国家健康与营养调查(NHANES)的代表性样本,计算了上述甲状腺激素抵抗指数。为了近似 TFQI,可以使用美国参考的参数 TFQI(PTFQI),使用电子表格公式= NORM.DIST(fT4_cell_in_pmol_per_L,10.075,2.155,TRUE)+ NORM.DIST(LN(TSH_cell_in_mIU_per_L),0.4654,0.7744,TRUE)-1。感兴趣的结局为糖化血红蛋白≥6.5%、使用糖尿病药物、糖尿病相关死亡(糖尿病为死亡原因),此外,在禁食亚组中,还包括糖尿病和代谢综合征。采用逻辑回归和泊松回归模型,对性别、年龄和种族/民族进行了调整。

结果

TFQI 四分位间距第四分位比第一分位的比值为 1.73(95%CI 1.32,2.27)( = 0.002),用于阳性糖化血红蛋白,比值为 1.66(95%CI 1.31,2.10)( = 0.001),用于药物治疗。TFQI 高于中位数与低于中位数的糖尿病相关死亡率比值为 4.81(95%CI 1.01,22.94)( = 0.015)。进一步调整 BMI 并限制为甲状腺功能正常个体,得到了相似的结果。TFQI 每增加 1 SD,糖尿病的比值增加 1.13(95%CI 1.02,1.25),代谢综合征的比值增加 1.16(95%CI 1.02,1.31)。其他甲状腺激素抵抗指数对糖尿病相关死亡和代谢综合征也有类似的关联。

结论

甲状腺激素抵抗指数较高与肥胖、代谢综合征、糖尿病和糖尿病相关死亡率有关。甲状腺激素抵抗可能反映了导致 2 型糖尿病的能量平衡问题。这些指数可能有助于监测以能量平衡为目标的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验